Physician profile
Tracy E Mccall
NPI 1013982834
$813.57
in general payments reported to CMS, 2019-2025
10 companies · $18.97 in 2025
The $18.97 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $426 · 2021: $96.48 · 2022: $35.65 · 2023: $106 · 2024: $130 · 2025: $18.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $389.73 | 2020 | |
| Kerecis Limited | $189.81 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $42.84 | 2023-2025 | |
| Acell, INC. | $36.60 | 2020 | |
| Endo Pharmaceuticals INC. | $33.94 | 2021-2022 | |
| Integra Lifesciences Corporation | $28.32 | 2021 | |
| Mentor Worldwide LLC | $28.03 | 2021-2022 | |
| Sientra, INC. | $25.54 | 2021 | |
| Solventum Corporation | $22.46 | 2024 | Activ.A.C. |
| Kci USA, INC. | $16.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.